Primary care management for patients receiving long-term antithrombotic treatment: A cluster-randomized controlled trial

PLoS One. 2019 Jan 9;14(1):e0209366. doi: 10.1371/journal.pone.0209366. eCollection 2019.

Abstract

Purpose: To examine whether applying case management in general practices reduces thromboembolic events requiring hospitalization and major bleeding events (combined primary outcome). Secondary endpoints were mortality, frequency and duration of hospitalization, severe treatment interactions, adverse events, quality of anticoagulation, health-related quality of life and intervention costs, patients' assessment of chronic illness care, self-reported adherence to medication, GP and HCA knowledge, patient knowledge and satisfaction with shared decision-making.

Methods: Cluster-randomized controlled trial undertaken at 52 general practices in Germany with adult patients with a long-term indication for oral anticoagulation. The complex intervention included training for healthcare assistants, information and quality circles for general practitioners and 24 months of case management for patients. Assessment was after 12 and 24 months. The intention-to-treat population included all randomized practices and patients, while the per-protocol analysis included only those that received treatment without major protocol violations.

Results: The mean (SD) age of the 736 patients was 73.5 (9.4) years and 597 (81.1%) had atrial fibrillation. After 24 months, the primary endpoint had occurred in 40 (11.0%) intervention and 48 (12.9%) control patients (hazard ratio 0.83, 95% CI 0.55 to 1.25; P = .37). Patients' perceived quality of care, their knowledge, and HCAs' knowledge, had improved significantly at 24 months. The other secondary endpoints did not differ between groups. In the intervention group, hospital admissions were significantly reduced in patients that received treatment without major protocol deviations.

Conclusions: Even though the main outcomes did not differ significantly, the intervention appears to have positively influenced several process parameters under 'real-world conditions'.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Case Management*
  • Cluster Analysis
  • Endpoint Determination
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • General Practice
  • Germany
  • Hemorrhage / etiology
  • Hospitalization
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Outcome Assessment, Health Care
  • Patient Medication Knowledge
  • Patient Satisfaction
  • Primary Health Care*
  • Quality of Life
  • Thromboembolism / etiology
  • Time Factors

Substances

  • Fibrinolytic Agents

Grants and funding

This study was funded by the German Federal Ministry of Education and Research (grant number 01GY1145). The funding body had no role in study design, data collection, data analysis, data interpretation, writing the report, or the decision to submit this paper for publication. None of the authors have been paid by a pharmaceutical company or another for-profit organization to write this article. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.